stockrow
Friday 6 November 2026
Export SOLV’s income statement to Excel — free account
Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
86.56
2.79
−3.12%
Follow SOLV
Alert me
Solventum Corporation (SOLV) Net margin
Solventum Corporation's net margin over the twelve months to 30 September 2026 was 1.91%, down 16.8 percentage points from fiscal 2025 (18.7%). That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 18.7% | 12.89 |
| FY2024 | 5.80% | (10.62) |
| FY2023 | 16.4% | (0.10) |
| FY2022 | 16.5% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | −0.62% | (4.78) |
| Jun 2026 | 4.16% | 3.51 |
| Mar 2026 | 0.65% | (2.50) |
| Dec 2025 | 3.15% | (57.25) |
| 11 more quarters | Free account |
Net margin against peers
| Company | Net margin |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 18.8% |
| COO The Cooper Companies, Inc. compare | 13.5% |
| ALGN Align Technology, Inc. compare | 11.8% |
| ATR AptarGroup, Inc. compare | 6.69% |
| AVTR Avantor, Inc. compare | 5.08% |
| SOLV Solventum Corporation | 1.91% |
| RGEN Repligen Corporation compare | −1.47% |
| BLCO Bausch + Lomb Corporation compare | −2.05% |
| BAX Baxter International Inc. compare | −6.23% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement